Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesNew Anti-Rejection Drug Saves Money, Lives
Ivanhoe, 10/19/09
A newer, less expensive drug used to prevent organ rejection has been shown to be equally as effective and safe as its more expensive counterpart. In a study researchers compared the effectiveness of two drugs used to reduce the chances of rejection in kidney and pancreas transplants: alemtuzumab, a new drug that costs about $1,000 per treatment, and rabbit antithymocyte globulin, which costs about four times as much. Both drugs are used in short–term treatment to rapidly lower the immune system and thus prevent organ rejection.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Heart drugs show promise for fighting colon cancer
EurekAlert, 12/17/09
Should flowers be banned in hospitals
EurekAlert, 12/17/09
Women Tend to Have Better Sense of Touch Due to Smaller Finger Size
ScienceDaily, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor